Logo image of CXAI

CXAPP INC (CXAI) Stock Fundamental Analysis

NASDAQ:CXAI - Nasdaq - US23248B1098 - Common Stock - Currency: USD

1.02  -0.01 (-0.97%)

After market: 1.02 0 (0%)

Fundamental Rating

1

CXAI gets a fundamental rating of 1 out of 10. The analysis compared the fundamentals against 284 industry peers in the Software industry. CXAI may be in some trouble as it scores bad on both profitability and health. CXAI has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

In the past year CXAI has reported negative net income.
CXAI had a negative operating cash flow in the past year.
The reported net income has been mixed in the past 5 years: CXAI reported negative net income in multiple years.
CXAI had a negative operating cash flow in each of the past 5 years.
CXAI Yearly Net Income VS EBIT VS OCF VS FCFCXAI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 2024 0 -20M -40M

1.2 Ratios

Looking at the Return On Assets, with a value of -54.20%, CXAI is doing worse than 85.21% of the companies in the same industry.
Looking at the Return On Equity, with a value of -101.65%, CXAI is doing worse than 76.06% of the companies in the same industry.
Industry RankSector Rank
ROA -54.2%
ROE -101.65%
ROIC N/A
ROA(3y)-2.25%
ROA(5y)-0.98%
ROE(3y)1279.74%
ROE(5y)768.23%
ROIC(3y)N/A
ROIC(5y)N/A
CXAI Yearly ROA, ROE, ROICCXAI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 2024 0 1K 2K 3K 4K

1.3 Margins

CXAI has a better Gross Margin (83.08%) than 91.20% of its industry peers.
CXAI does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 83.08%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
CXAI Yearly Profit, Operating, Gross MarginsCXAI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 2024 0 -200 -400 -600

More info and screens

1

2. Health

2.1 Basic Checks

CXAI does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for CXAI has been increased compared to 1 year ago.
CXAI has a worse debt/assets ratio than last year.
CXAI Yearly Shares OutstandingCXAI Yearly Shares OutstandingYearly Shares Outstanding 2020 2021 2022 2023 2024 5M 10M 15M
CXAI Yearly Total Debt VS Total AssetsCXAI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2020 2021 2022 2023 2024 50M 100M 150M 200M 250M

2.2 Solvency

Based on the Altman-Z score of -4.34, we must say that CXAI is in the distress zone and has some risk of bankruptcy.
The Altman-Z score of CXAI (-4.34) is worse than 81.69% of its industry peers.
CXAI has a Debt/Equity ratio of 0.27. This is a healthy value indicating a solid balance between debt and equity.
Looking at the Debt to Equity ratio, with a value of 0.27, CXAI is in line with its industry, outperforming 41.55% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.27
Debt/FCF N/A
Altman-Z -4.34
ROIC/WACCN/A
WACC10.46%
CXAI Yearly LT Debt VS Equity VS FCFCXAI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2020 2021 2022 2023 2024 0 50M 100M 150M 200M 250M

2.3 Liquidity

A Current Ratio of 0.57 indicates that CXAI may have some problems paying its short term obligations.
With a Current ratio value of 0.57, CXAI is not doing good in the industry: 88.38% of the companies in the same industry are doing better.
CXAI has a Quick Ratio of 0.57. This is a bad value and indicates that CXAI is not financially healthy enough and could expect problems in meeting its short term obligations.
CXAI has a Quick ratio of 0.57. This is amonst the worse of the industry: CXAI underperforms 88.03% of its industry peers.
Industry RankSector Rank
Current Ratio 0.57
Quick Ratio 0.57
CXAI Yearly Current Assets VS Current LiabilitesCXAI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2020 2021 2022 2023 2024 2M 4M 6M 8M 10M

More info and screens

2

3. Growth

3.1 Past

CXAI shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 72.57%, which is quite impressive.
CXAI shows a decrease in Revenue. In the last year, the revenue decreased by -9.40%.
EPS 1Y (TTM)72.57%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%75.85%
Revenue 1Y (TTM)-9.4%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-32.67%

3.2 Future

The Earnings Per Share is expected to grow by 26.36% on average over the next years. This is a very strong growth
Based on estimates for the next years, CXAI will show a small growth in Revenue. The Revenue will grow by 3.28% on average per year.
EPS Next Y36.29%
EPS Next 2Y26.36%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year-33.33%
Revenue Next 2Y3.28%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

CXAI Yearly Revenue VS EstimatesCXAI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2023 2024 2025 2026 2M 4M 6M 8M
CXAI Yearly EPS VS EstimatesCXAI Yearly EPS VS EstimatesYearly EPS VS Estimates 2023 2024 2025 2026 -0.2 -0.4 -0.6 -0.8 -1

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for CXAI. In the last year negative earnings were reported.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for CXAI. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
CXAI Price Earnings VS Forward Price EarningsCXAI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40 60

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
CXAI Per share dataCXAI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.5 -0.5

4.3 Compensation for Growth

CXAI's earnings are expected to grow with 26.36% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y26.36%
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

No dividends for CXAI!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

CXAPP INC

NASDAQ:CXAI (6/10/2025, 8:00:01 PM)

After market: 1.02 0 (0%)

1.02

-0.01 (-0.97%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)05-20 2025-05-20/amc
Earnings (Next)08-11 2025-08-11
Inst Owners6.66%
Inst Owner Change17.05%
Ins Owners19.09%
Ins Owner Change170.68%
Market Cap21.20M
Analysts82.86
Price Target3.06 (200%)
Short Float %10.39%
Short Ratio0.25
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)38.73%
Min EPS beat(2)10.13%
Max EPS beat(2)67.32%
EPS beat(4)2
Avg EPS beat(4)5.82%
Min EPS beat(4)-30.72%
Max EPS beat(4)67.32%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-24%
Min Revenue beat(2)-29.41%
Max Revenue beat(2)-18.58%
Revenue beat(4)1
Avg Revenue beat(4)-12.12%
Min Revenue beat(4)-29.41%
Max Revenue beat(4)3.32%
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-25%
PT rev (3m)-40%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)-36.21%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)-44.44%
Revenue NY rev (3m)-66.67%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 3.24
P/FCF N/A
P/OCF N/A
P/B 1.36
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-0.96
EYN/A
EPS(NY)-0.51
Fwd EYN/A
FCF(TTM)-0.37
FCFYN/A
OCF(TTM)-0.37
OCFYN/A
SpS0.32
BVpS0.75
TBVpS-0.38
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -54.2%
ROE -101.65%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 83.08%
FCFM N/A
ROA(3y)-2.25%
ROA(5y)-0.98%
ROE(3y)1279.74%
ROE(5y)768.23%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover0.22
Health
Industry RankSector Rank
Debt/Equity 0.27
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 0.54%
Cap/Sales 0.23%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.57
Quick Ratio 0.57
Altman-Z -4.34
F-Score4
WACC10.46%
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)72.57%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%75.85%
EPS Next Y36.29%
EPS Next 2Y26.36%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-9.4%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-32.67%
Revenue Next Year-33.33%
Revenue Next 2Y3.28%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y9.22%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year31.94%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y25.69%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y25.25%
OCF growth 3YN/A
OCF growth 5YN/A